BRD2 and metabolic syndrome: An increase in serum FSH levels was associated with a 25.0% (OR: 0.750; 95% CI: 0.965, 0.535; and P= 0.011) lower risk of MetS in perimenopausal women and 21.9% (OR: 0.781; 95% CI: 0.916, 0.646; and P= 0.003) in postmenopausal women.